“Avicenna – A Strategy for in silico Clinical Trials” was a Coordination and Support Action funded by the European Commission. Avicenna was tasked with writing a Roadmap to define the strategy for developing In Silico Clinical Trials.
SYSBIO2016 is the 6th course dedicated to training of systems biologists, by providing training in both experimental biology and theoretical modelling of biological data.
The main goal of the CombiMS project is to identify a new method for drug discovery based on systems biology and to validate this approach by identifying novel combination therapies for Multiple Sclerosis.
In this paper a validated gene regulatory network of T cell differentiation was constructed in order to identify potential early regulators of T cell associated diseases.
The ultimate aim of the Avicenna action is to create a research and technological development Roadmap outlining a strategy for in silico Clinical Trials.
The main goal of the PRIAT Project consists in the development and use of HLA peptidome analysis for the study of interpatient and intrapatient variations in the immunopeptidome in response to antibody treatment.
The biennial ISGSB meetings are devoted to advancing the biological sciences by exploring the interplay between mathematical modelling, computer simulation and wet-lab experiments.